视网膜静脉阻塞的诊断与治疗研究进展  

Research progress of the diagnosis and treatment for retinal vein occlusion

作　　者：王彬[1] 贾淑琴[2] 霍建新[1] 

机构地区：[1]包头医学院第一附属医院眼科,中国内蒙古自治区包头市014010 [2]中国内蒙古自治区巴彦淖尔市医院眼科,015000

出　　处：《国际眼科杂志》2014年第7期1227-1230,共4页International Eye Science

摘　　要：视网膜静脉阻塞(retinal vein occlusion,RVO)是一种常见的视网膜血管疾病,是致盲的主要原因之一。近年来有关RVO的诊断及治疗措施等都有了一些新的认识和进步,特别是在治疗上有了一些新的研究,即玻璃体腔注射曲安奈德(triamcinolone acetonide,TA)、地塞米松植入物(Ozurdex)和抗血管内皮生长因子(vascular endothelial growth factor,VEGF)药物在RVO的应用。本文就近年来有关RVO的诊断及治疗研究进展综述如下。Retinal vein occlusion （RVO） is a common vascular disease of the retina and is one of the main reasons for blindness. In recent years, there have been some new understanding about the diagnosis and treatment of the disease, especially some new researches about treatment,for example , in the therapy of the intravitreal injection of triamcinolone acetonide and anti-VEGFs as well as dexamethasone implant （Ozurdex）. This article will make a brief summarization of the progress about the diagnosis and treatment of RVO.

关 键 词：视网膜静脉阻塞 玻璃体腔注射 地塞米松植入物 光学相干断层扫描技术 

分 类 号：R774.1[医药卫生—眼科]